在化诱导的干细胞功能障碍中表皮和介质干细胞机密体的潜在治疗作用
Agnieszka Prusek-Kucharek1, Bartosz Sikora1, Piotr Czekaj1
1Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
Cells
|November 26, 2025
概括
条件介质 (CM) 中的干细胞分泌体显示出治疗干眼疾病 (DED) 的前景. CM显著减少了甲 (BAC) 对眼皮表面干细胞的损伤,促进了再生.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 干眼病 (DED) 是一种普遍存在的眼睛表面疾病.
- 眼药中的甲化物 (BAC) 等防腐剂可以加剧DED.
- 目前的DED治疗方法往往不够,需要新的治疗方法.
研究的目的:
- 研究干细胞衍生在条件介质 (CM) 中的神秘体的潜力,用于眼表面再生.
- 评估从人类脂肪衍生干细胞 (hADSC) 和羊水膜衍生细胞中获得的CM在保护和再生受BAC损伤的肢体干细胞 (LSC) 的有效性.
- 为了比较CM的保护和治疗效果,当与BAC暴露同时或之后应用时.
主要方法:
- 采用了两种实验模型:同时使用CM和BAC,同时使用CM治疗受伤后.
- 该研究通过测量细胞亡,细胞循环进展,增殖,迁移和炎症来评估CM对LSC的影响.
- CM是由hADSCs和胚胎膜衍生细胞衍生而来的.
主要成果:
- 来自hADSC和羊水细胞的CM显著减轻了BAC诱导的LSC损伤.
- 所有经过测试的CM配方都显示出对LSCs的再生潜力,具有不同程度的疗效.
- 同时在BAC暴露期间使用CM,与受伤后治疗相比,提供了更强大和更一致的保护性益处.
结论:
- 在CM中,干细胞衍生分泌体代表了通过保护和再生眼表面干细胞来管理DED的有希望的治疗策略.
- 应用CM的时机至关重要,同时暴露显示出优异的结果.
- 对基于CM的治疗方法的进一步研究可能会导致改善防腐剂诱导的眼睛表面损伤的治疗方法.
相关概念视频
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K


